IMI - Call 15: Immunology, drug development and synaptopathies

IMI-2 (Innovative medicines initiative) - has launched six topics for research projects.Deadline October 24th, 2018.

Calls focus on immunology, drug development and synaptopathy. The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. Consortia consist of partners from industry, academia, and small and medium-sized enterprises (SME).


Webinars on the call topics were held in July. Click to access presentations, recordings and lists of participants.


A two-stage application is foreseen. Academic/SME consortia will apply in stage 1. The winning academic/SME consortium and the industry consortium will write a joint, final application to be subjected to a go/no go decision. The stage 1 deadline is October 24th, 2018.

IMI Webpage

Published June 1, 2018 11:09 AM - Last modified Aug. 2, 2018 11:11 AM